Clik here to view.
Acucela Licenses Gene Therapy from The University of Manchester for Retinal...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
AntiCancer Inc. and Japanese Scientists Make Beating Heart-Muscle Tissue...
SAN DIEGO AntiCancer Inc. and Japanese scientists from Kitasato University near Tokyo have made beating heart-muscle tissue sheets from hair-follicle-associated pluripotent (HAP) stem cells. HAP...
View ArticleClik here to view.
新临床研究报道：手术中的Masimo氧储备指数(ORI™)与动脉氧分压相关
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，一项新的回顾性研究报道，手术中的Masimo氧储备指数(ORI™)与动脉氧分压(PaO2)相关。该研究提示，根据ORI与PaO2之间的相关趋势，ORI有可能作为手术中成人即将发生去氧饱和的高级指标。1 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
ノボキュア社と著名ながんセンターが腫瘍治療電場の前臨床研究で提携
ジャージー島セントヘリア （ビジネスワイヤ） — ノボキュア社（NASDAQ: NVCR）は本日、ノボキュア社のinovitro™システムがテキサス大学MDアンダーソンがんセンターにおいて腫瘍治療電場（Tumor Treating...
View ArticleClik here to view.
Shinkowa Pharmaceutical: The World’s First NMN Dietary Supplement Specialized...
TOKYO Shinkowa Pharmaceutical Co., Ltd. today announced the world’s first NMN dietary supplement now available on the US Amazon. The NMN dietary supplement has been developed under the brand name of...
View ArticleClik here to view.
CANbridge Submits Investigational New Drug Application to Taiwan Food and...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has completed the Investigational New Drug (IND)...
View ArticleClik here to view.
ファインデックス、GEヘルスケア・ジャパンへ放射線ソリューションをODM提供
愛媛県松山市 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京・愛媛 社長：相原輝夫）は、放射線領域ソリューションのより活発な展開・推進を目的とし、放射線部門システム、放射線読影システムなどの製品をGEヘルスケア・ジャパン株式会社（本社：東京都日野市旭が丘4-7-127 代表取締役社長兼CEO：川上 潤、以下GEヘルスケア）に対してODM（Original...
View ArticleClik here to view.
Mach7 Technologies and 3D Medical Complete Merger
BURLINGTON, Vt. Mach7 Technologies and 3D Medical (ASX:3DM) today announced the completion of their merger. The combined company will bring advanced medical image management solutions to customers...
View ArticleClik here to view.
HCCA named Best Emerging IT-BPM Company for Healthcare at International ICT...
NASHVILLE, Tenn. HCCA, which provides a full spectrum of URAC-accredited Clinical Process Outsourcing (CPO) services, was named Best Emerging IT-BPM Company for Healthcare at the annual...
View ArticleClik here to view.
St George’s University: Top medical university highlights a fifth of students...
ST GEORGE’S, Grenada As it celebrates its 40th anniversary year, St George’s University (SGU) in Grenada has highlighted the significant contribution it has made to training medical professionals...
View ArticleClik here to view.
Chi-Med Initiates First-in-Human Clinical Trial of Novel PI3K Inhibitor HMPL-689
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated the first-in-human (“FIH”)...
View ArticleClik here to view.
Nominees Announced for 2016-2017 Pioneers in Performance Awards for Latin...
FLAGSTAFF, Ariz. & SÃO PAULO W. L. Gore & Associates, Inc. (Gore) today announced the nominees and opening of voting for the 2016-2017 Pioneers in Performance Awards for Latin America at the...
View ArticleClik here to view.
Hutchison China MediTech Limited Announces Exercise of Overallotment Option
LONDON Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that the underwriters of its offering of American depositary shares (“ADSs”) on the Nasdaq Global Select Market (the...
View ArticleClik here to view.
2016-2017年度拉丁美洲表现先锋奖被提名者公布
亚利桑那州弗拉格斯塔夫和巴西圣保罗 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天在巴西圣保罗召开的国际血管内外科大会(CICE) 2016年度研讨会上宣布了 2016-2017年度拉丁美洲表现先锋奖的被提名者和投票的启动。...
View ArticleClik here to view.
2016～2017年「パフォーマンスのパイオニア賞（中南米）」の受賞候補者を発表
米アリゾナ州フラッグスタッフ & サンパウロ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、サンパウロで開催中の「2016年血管内手術国際会議」（Congreso Internacional Cirugia Endovascular...
View ArticleClik here to view.
Sosei Subsidiary Heptares and Kymab Enter Strategic Collaboration to...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565) today announces Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, and Kymab Limited, a leading human...
View ArticleClik here to view.
Article 0
ロンドン （ビジネスワイヤ） — アストラゼネカは本日、非小細胞肺がん（NSCLC）患者のファーストライン治療およびセカンドライン治療の両方でオシメルチニブを検討する第1相延長試験の追跡データを、2016年欧州肺がん学会（ELCC）で発表しました。最新演題の発表内容はAURA臨床試験プログラムですでに示されたオシメルチニブの有効性／安全性プロファイルを補強するものでした。...
View ArticleClik here to view.
Acucela Announces End of Treatment Period in Phase 2b/3 Clinical Trial of...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
美国临床肿瘤学会支持WIN 2016研讨会：以创新途径改善癌症患者治疗效果
法国维勒瑞夫 –(美国商业资讯)–WIN联合会(WIN)自豪地宣布，其致力于“以创新途径改善癌症患者治疗效果”研讨会已获得美国临床肿瘤学会(ASCO®)的支持，列为该学会的优秀科学项目。WIN主席、MD安德森个体化癌症疗法研究所所长John Mendelsohn说：“这是ASCO®连续第8年支持这一独特的科学论坛，该论坛已成为精准癌症医学领域的重要活动。” WIN...
View ArticleClik here to view.